These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 25571761)
21. [Role of muscle and fat tissue in the pathogenesis of type 2 diabetes]. Blüher M; Stumvoll M Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S231-5. PubMed ID: 17139576 [TBL] [Abstract][Full Text] [Related]
22. [Atherogenic dyslipidaemia in type 2 diabetes]. Zozulińska D Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S567-71. PubMed ID: 20527378 [TBL] [Abstract][Full Text] [Related]
23. Diabetes in Zucker diabetic fatty rat. Shiota M; Printz RL Methods Mol Biol; 2012; 933():103-23. PubMed ID: 22893404 [TBL] [Abstract][Full Text] [Related]
24. Metabolic characteristics of glucose intolerance: the critical role of obesity. Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239 [TBL] [Abstract][Full Text] [Related]
25. The role of adiponectin in obesity, diabetes, and cardiovascular disease. Kawano J; Arora R J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516 [TBL] [Abstract][Full Text] [Related]
26. [Pathogenesis of insulin resistance in IGT]. Asakawa H; Tokunaga K Nihon Rinsho; 1997 Nov; 55 Suppl():822-6. PubMed ID: 9434571 [No Abstract] [Full Text] [Related]
27. Diabetes mellitus in the era of proteomics. Korc M Mol Cell Proteomics; 2003 Jun; 2(6):399-404. PubMed ID: 12851465 [No Abstract] [Full Text] [Related]
28. Obesity, insulin resistance, and type 2 diabetes in children and adolescents. Rappaport EB; Usher DC Pediatr Ann; 2006 Nov; 35(11):822-6. PubMed ID: 17153129 [No Abstract] [Full Text] [Related]
29. Association of obesity and leptin with insulin resistance in type 2 diabetes mellitus in Indian population. Das P; Bhattacharjee D; Bandyopadhyay SK; Bhattacharya G; Singh R Indian J Physiol Pharmacol; 2013; 57(1):45-50. PubMed ID: 24020098 [TBL] [Abstract][Full Text] [Related]
30. [Pathogenesis of diabetes type II]. Tatoń J; Szczeklik Z; Czech A Pol Tyg Lek; 1995; Suppl 1():70-7. PubMed ID: 7596915 [No Abstract] [Full Text] [Related]
31. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944 [TBL] [Abstract][Full Text] [Related]
32. Improvement of glucose homeostasis after weight loss in obese children. Santoro N; Di Nardo M; Amato A; Perrone L; del Giudice EM Pediatrics; 2005 May; 115(5):1441; author reply 1441-2. PubMed ID: 15867067 [No Abstract] [Full Text] [Related]
33. [Mechanisms of insulin resistance]. Mäkinen S; Skrobuk P; Nguyen YH; Koistinen H Duodecim; 2013; 129(20):2115-22. PubMed ID: 24340711 [TBL] [Abstract][Full Text] [Related]
34. Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. von Eckardstein A; Sibler RA Curr Opin Lipidol; 2011 Feb; 22(1):26-32. PubMed ID: 21102330 [TBL] [Abstract][Full Text] [Related]
35. CXCL5 drives obesity to diabetes, and further. Chavey C; Fajas L Aging (Albany NY); 2009 Jul; 1(7):674-7. PubMed ID: 20157549 [TBL] [Abstract][Full Text] [Related]
36. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Meyer MR; Clegg DJ; Prossnitz ER; Barton M Acta Physiol (Oxf); 2011 Sep; 203(1):259-69. PubMed ID: 21281456 [TBL] [Abstract][Full Text] [Related]
37. GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance. Tiwari A Curr Opin Investig Drugs; 2010 Apr; 11(4):385-93. PubMed ID: 20336586 [TBL] [Abstract][Full Text] [Related]